Nellcor gains respiratory products in Puritan-Bennett deal
This article was originally published in Clinica
Executive Summary
Nellcor will take over Puritan-Bennett in a stock-for-stock transaction worth about $475 million. The deal will combine worldwide leaders in two complementary areas - patient monitoring and respiratory therapy - Nellcor says. The new company, Nellcor/Puritan-Bennett, will provide a line of products to diagnose, monitor and treat patients with respiratory difficulties in the hospital, alternative care sites and the home.